
An investor, who purchased shares of NeoGenomics, Inc. (NASDAQ:NEO), filed a lawsuit over alleged violations of Federal Securities Laws by NeoGenomics, Inc. in connection with certain allegedly false and misleading statements made between February 27, 2020 and April 26, 2022.